Validity and Reliability of the Turkish Version of the Tegner Activity Score
Launched by KIRKLARELI UNIVERSITY · Aug 22, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a tool called the Turkish version of the Tegner Activity Score, which helps measure how active people are after having surgery for a knee injury, specifically a torn anterior cruciate ligament (ACL). The researchers want to find out if this score is a reliable and accurate way to assess activity levels in Turkish-speaking patients and learn about its importance in understanding recovery after surgery.
To participate in this study, you need to be at least 18 years old and scheduled for surgery to fix a torn ACL. Unfortunately, if you have certain medical conditions, such as autoimmune diseases or cognitive issues that make it hard to fill out forms, or if you are not fluent in Turkish, you won’t be eligible to join. If you do participate, you can expect to complete some questionnaires about your activity levels, which will help improve how doctors understand recovery for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • to be over 18 years old
- • to undergo surgery for a ruptured anterior cruciate ligament
- Exclusion Criteria:
- • to have metabolic or autoimmune diseases
- • to undergo revision anterior cruciate ligament surgery or anterior cruciate ligament repair
- • to have cognitive issues that will hinder the completion of the study forms
- • to lack sufficient proficiency in Turkish
About Kırklareli University
Kırklareli University is a distinguished academic institution dedicated to advancing medical research and clinical innovation. With a commitment to enhancing healthcare outcomes, the university actively sponsors clinical trials that leverage cutting-edge methodologies and interdisciplinary collaboration. Its research programs are designed to address pressing medical challenges, fostering an environment that encourages rigorous scientific inquiry and ethical practices. By engaging with local and international partners, Kırklareli University aims to contribute significantly to the advancement of medical knowledge and the development of effective therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Ozan Gür, MSc
Principal Investigator
Kırklareli University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported